Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey

This publication has 135 references indexed in Scilit:

• In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections
  Diagnostic Microbiology and Infectious Disease, 2004
• Suppression of Drug‐Resistant Staphylococcal Infections by the Quorum‐Sensing Inhibitor RNAIII‐Inhibiting Peptide
  The Journal of Infectious Diseases, 2004
• Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent gram-positive clinical isolates
  Diagnostic Microbiology and Infectious Disease, 2004
• Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines
  American Heart Journal, 2004
• RWJ-54428 (MC-02,479), a New Cephalosporin with High Affinity for Penicillin-Binding Proteins, Including PBP 2a, and Stability to Staphylococcal Beta-Lactamases
  Antimicrobial Agents and Chemotherapy, 2003
• Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients
  The Lancet, 2002
• Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving Hemodialysis
  New England Journal of Medicine, 2002
• BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental Endocarditis
  Antimicrobial Agents and Chemotherapy, 2002
• Evolution of an inducible penicillin‐target protein in methicillin‐resistant Staphylococcus aureus by gene fusion
  FEBS Letters, 1987
• Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus
  Journal of Antimicrobial Chemotherapy, 1987